Skip to main content
Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
7.70
-0.12 (-1.53%)
At close: Apr 28, 2026, 4:00 PM EDT
7.55
-0.15 (-1.95%)
After-hours: Apr 28, 2026, 6:21 PM EDT

Silence Therapeutics Revenue

In the year 2025, Silence Therapeutics had annual revenue of $559.00K, down -98.71%. Silence Therapeutics had revenue of $34.00K in the quarter ending December 31, 2025, a decrease of -99.87%.

Revenue (ttm)
$559.00K
Revenue Growth
-98.71%
P/S Ratio
650.63
Revenue / Employee
$6,352
Employees
88
Market Cap
363.70M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025559.00K-42.70M-98.71%
Dec 31, 202443.26M11.62M36.71%
Dec 31, 202331.64M9.99M46.12%
Dec 31, 202221.66M4.84M28.82%
Dec 31, 202116.81M9.33M124.73%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Puma Biotechnology 228.37M
Autolus Therapeutics 75.39M
X4 Pharmaceuticals 35.11M
Opus Genetics 14.20M
Ovid Therapeutics 7.25M
Armata Pharmaceuticals 4.90M
YD Bio 510.36K
Revenue Rankings

SLN News

More News